Evaluation of a New Technology for the Treatment of Bladder Leakage in Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-06

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of a new technology for the treatment of bladder leakage in women. The objective is to compare quality of life and other incontinence associated outcomes between women receiving routine General Practitioner (GP) prescribed care for urinary incontinence compared with those prescribed the electrical stimulation device.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence

NCT00762593

Urinary Stress Incontinence

UNKNOWN PHASE2

Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.

NCT02377765

Overactive Bladder

COMPLETED NA

Peripheral Electrical Stimulation for the Treatment of Overactive Bladder

NCT01783392

Idiopathic Overactive Bladder

COMPLETED NA

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

NCT04001426

Urinary Bladder, Overactive

COMPLETED NA

Effects of External Neuromuscular Electrical Stimulation in Women With Urgency Urinary Incontinence

NCT04727983

Physiotherapy Women's Health Urge Incontinence +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This United Kingdom study will comprise a single blind, primary care, post-market evaluation of a novel neuromuscular electrical stimulation treatment for urinary incontinence . Women with GP determined urinary incontinence (urgency, stress or mixed) will be randomised into one of two groups (intervention or control). The control group will receive routine care via their GP practice. The intervention group will receive the electrical stimulation device. Treatment will last for 12 weeks with a Quality of Life (QoL) primary end point immediately post treatment with a second phase to explore the impact of a further 12 weeks maintenance programme in the intervention group compared to routine care. There will be a further two year follow-up assessment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Incontinence Urinary Incontinence, Stress Urinary Incontinence, Urge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electrical stimulation

Neuromuscular electrical stimulation treatment

Group Type EXPERIMENTAL

Electrical stimulation

Intervention Type DEVICE

Electrical stimulation device

Treatment As Usual

Usual GP treatment

Group Type ACTIVE_COMPARATOR

Treatment as usual

Intervention Type OTHER

GP treatment as usual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrical stimulation

Electrical stimulation device

Intervention Type DEVICE

Treatment as usual

GP treatment as usual

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* Aged between 18 and 65
* GP determined urinary incontinence

Exclusion Criteria

* Abnormal abdominal mass
* Clinical history of urinary retention problems
* Severe atrophic vaginitis, vaginal infection, vaginal lesion, severe urogenital prolapse at the level of the vaginal introitus or any other pathology of the vagina or labia
* Pregnancy or given birth within the last three months
* Implanted pacemaker
* Recent pelvic surgery (within the last 12 months)
* Recent haemorrhage, haematoma and/or tissue damage to the vagina
* Undergoing any active therapy or review appointments for pelvic malignancy
* Current urinary tract infection confirmed by urinary dip stick test on initial visit (can be included following a subsequent clear urinary dipstick test)
* Manual dexterity insufficient to place the electrical stimulation device in the vagina
* Presence of a severe neurological conditions such as Multiple Sclerosis, Motor Neuron Disease or Parkinson's Disease
* Multiple co-morbidities to the extent that the activities involved in the pad test (i.e. stair climbing) cannot be completed
* Insufficient cognitive ability to provide informed consent and/or participate in the study
* Unwillingness to participate in the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes